This session focuses on the impact and pattern of emerging infections – both bacterial and viral. Antibiotic resistance, implications for treatment and management, and vaccine development are discussed.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 11/8/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP17499.

ANNA urges participants to be aware of the CNE requirements for relicensure in the states in which they hold a license.

Learning Outcome:
Upon completion of this session the learner will be able to discuss the impact and pattern of emerging bacterial and viral infections, antibiotic resistance, vaccine development, and the role healthcare providers play in infection prevention.